Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Preliminary evaluation of a predictive blood assay to identify patients at high risk of chemotherapy-induced nausea.

Kutner T, Kunkel E, Wang Y, George K, Zeger EL, Ali ZA, Prendergast GC, Gilman PB, Wallon UM.

Support Care Cancer. 2017 Feb;25(2):581-587. doi: 10.1007/s00520-016-3442-5. Epub 2016 Oct 12.

PMID:
27734152
2.

Metastasis to the Cervix Uteri 15 Years After Treatment of Lobular Carcinoma of the Breast.

Waks AG, Lennon J, Yadav BS, Hwang H, dSchapirael Carmen M, Johnson NB, Reynolds K, Schapira L, Gilman PB, Overmoyer B.

Semin Oncol. 2015 Aug;42(4):e81-94. doi: 10.1053/j.seminoncol.2015.07.002. Epub 2015 Jul 6. No abstract available.

PMID:
26320072
3.

Characterization of the apoptotic response induced by the cyanine dye D112: a potentially selective anti-cancer compound.

Yang N, Gilman P, Mirzayans R, Sun X, Touret N, Weinfeld M, Goping IS.

PLoS One. 2015 Apr 30;10(4):e0125381. doi: 10.1371/journal.pone.0125381. eCollection 2015.

4.

Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.

Guo Y, Jones D, Palmer JL, Forman A, Dakhil SR, Velasco MR, Weiss M, Gilman P, Mills GM, Noga SJ, Eng C, Overman MJ, Fisch MJ.

Support Care Cancer. 2014 May;22(5):1223-31. doi: 10.1007/s00520-013-2075-1. Epub 2013 Dec 22.

PMID:
24362907
5.

The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study.

Cleeland CS, Zhao F, Chang VT, Sloan JA, O'Mara AM, Gilman PB, Weiss M, Mendoza TR, Lee JW, Fisch MJ.

Cancer. 2013 Dec 15;119(24):4333-40. doi: 10.1002/cncr.28376. Epub 2013 Sep 24.

6.

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C, Le-Lindqwister N, Gilman PB, Shapiro CL; Alliance for Clinical Trials in Oncology.

JAMA. 2013 Apr 3;309(13):1359-67. doi: 10.1001/jama.2013.2813.

7.

Full-term pregnancy and vaginal delivery after treatment for non-Hodgkin's lymphoma of the cervix and lower uterine segment: a case report.

Parva M, Lamb K, Savior DC, Gilman P, Belden M.

J Obstet Gynaecol Can. 2011 Jun;33(6):620-624. doi: 10.1016/S1701-2163(16)34911-8.

PMID:
21846452
8.

Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma.

Shen X, Denittis A, Werner-Wasik M, Axelrod R, Gilman P, Meyer T, Treat J, Curran WJ, Machtay M.

Radiat Oncol. 2011 Feb 16;6:17. doi: 10.1186/1748-717X-6-17.

9.

Cancer genetics evaluation: barriers to and improvements for referral.

Brandt R, Ali Z, Sabel A, McHugh T, Gilman P.

Genet Test. 2008 Mar;12(1):9-12. doi: 10.1089/gte.2007.0036.

PMID:
18373400
10.

Ecological risk assessment issues identified during the U.S. Environmental Protection Agency's examination of risk assessment practices.

Dearfield KL, Bender ES, Kravitz M, Wentsel R, Slimak MW, Farland WH, Gilman P.

Integr Environ Assess Manag. 2005 Jan;1(1):73-6.

PMID:
16637150
11.

A conflict-of-interest policy for epidemiology.

Gilman P.

Epidemiology. 2006 May;17(3):250-1. No abstract available.

PMID:
16617270
12.

Basics of asset protection.

Stark B, Gilman PA.

J Med Pract Manage. 2005 Jan-Feb;20(4):207-9.

PMID:
15779521
13.

New EPA focus on sustainability.

Gilman P.

Science. 2004 May 28;304(5675):1243-7. No abstract available.

PMID:
15166347
14.

Combined therapy with topotecan and gemcitabine in patients with inoperable or metastatic non-small cell lung cancer.

Dabrow MB, Francesco MR, Gilman PB, Cantor R, Rose L, Meyer TJ.

Cancer Invest. 2003;21(4):517-25.

PMID:
14533441
15.

Supplemental Content

Loading ...
Support Center